Sanjeev Pathak

4PUBLICATIONS
5CO-AUTHORS
PharmacogenomicsChild and adolescent developmentToxicology (incl. clinical toxicology)Basic pharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 16, 2025
Pimavanserin safety in adult and elderly patients with neuropsychiatric symptoms related to neurodegenerative disease: An open-label extension study.

Wiesław J Cubała, Ana Berrio, Katherine Chi-Burris

|Nov 28, 2024
Natural history and clinical outcomes in patients with Alzheimer's disease-related psychosis by antipsychotic treatment status in the United States.

Sapna Rao, Joan Forns, Heather E Danysh

|Nov 27, 2018
Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled Study.

Sanjeev Pathak, Bradley Vince, Debra Kelsh

|Aug 14, 2018
Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial.

Sanjeev Pathak, Bradley Vince, Debra Kelsh

Pageof 1

Frequent Collaborators

1 joint publications

Sapna Rao

1 joint publications

Wiesław J Cubała

1 joint publications

Ana Berrio

1 joint publications

Gustavo Alva